What is the status of clinical trial NCT05650632?

NCT05650632 is currently recruiting. This is a Clinical Trial study for multiple myeloma sponsored by AbbVie. Status verified from ClinicalTrials.gov.

Live Status Check

NCT05650632 Recruiting Status

Q: Where is NCT05650632 recruiting?

NCT05650632 is recruiting at 26 locations across the United States.

Q: How do I enroll in NCT05650632?

To enroll in NCT05650632, check your eligibility on HelloStudys.com and complete the interest form. A coordinator will contact you about next steps.

Real-time enrollment status for this multiple myeloma clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 6:35 AM UTC

NCT05650632 Status Summary

NCT Number	NCT05650632
Recruiting Status	Recruiting
Condition	Multiple Myeloma
Phase	Clinical Trial
Target Enrollment	210 participants
Active Locations	26 sites in the US
Sponsor	AbbVie
Last Updated on CT.gov	July 6, 2026 (1 week ago)

About NCT05650632 Enrollment Status

As of July 13, 2026: Clinical trial NCT05650632 is currently recruiting participants. This clinical trial study for multiple myeloma is actively seeking new participants at 26 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT05650632

Is NCT05650632 still recruiting?

Yes, NCT05650632 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT05650632 recruiting?

This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT05650632?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT05650632 status last updated?

The official ClinicalTrials.gov record for NCT05650632 was last updated 1 week ago (July 6, 2026). HelloStudys verifies this status automatically.

Browse More Multiple Myeloma Trials

Multiple Myeloma Trials All Conditions →

Ready to Apply?

Check your eligibility for this clinical trial